Cargando…
Carglumic acid: an additional therapy in the treatment of organic acidurias with hyperammonemia?
BACKGROUND: Hyperammonemia in patients with methylmalonic aciduria (MMA) and propionic aciduria (PA) is caused by accumulation of propionyl-CoA which decreases the synthesis of N-acetyl-glutamate, the natural activator of carbamyl phosphate synthetase 1. A treatment approach with carglumic acid, the...
Autores principales: | Levrat, Virginie, Forest, Isabelle, Fouilhoux, Alain, Acquaviva, Cécile, Vianey-Saban, Christine, Guffon, Nathalie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262878/ https://www.ncbi.nlm.nih.gov/pubmed/18234091 http://dx.doi.org/10.1186/1750-1172-3-2 |
Ejemplares similares
-
Improving diagnosis of mitochondrial fatty-acid oxidation disorders
por: Vianey-Saban, Christine, et al.
Publicado: (2023) -
New developments in the treatment of hyperammonemia: emerging use of carglumic acid
por: Daniotti, Marta, et al.
Publicado: (2011) -
Use of carglumic acid in valproate‐induced hyperammonemia: 25 pediatric cases
por: Palomino Pérez, Laura María, et al.
Publicado: (2020) -
Effect of carglumic acid with or without ammonia scavengers on hyperammonaemia in acute decompensation episodes of organic acidurias
por: Chakrapani, Anupam, et al.
Publicado: (2018) -
Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study
por: Valayannopoulos, Vassili, et al.
Publicado: (2016)